Home > Healthcare > Medical Devices > Therapeutic Devices > U.S. Dialysis Market
U.S. Dialysis Market size was valued at more than USD 42 billion in 2022 and is poised to project nearly 4% CAGR from 2023 to 2032. Surge in the prevalence of end-stage renal failure patients worldwide is fueling industry expansion.
The rising number of end-stage renal disease (ESRD) patients across the U.S. will drive market expansion. ESRD is the terminal stage of chronic kidney disease (CKD), where kidney function declines to an extent where it is no longer possible for it to operate normally. The prevalence of ESRD cases is on the rise across the United States which is forcing patients with kidney failure to consider kidney transplants or dialysis.
High incidence of hypertension and blood pressure issues, and an expanding elderly population will drive the need for dialysis in the U.S. The geriatric population of the country aged 60 years and above is projected to be more prone to renal failures or kidney-related issues. Such as scenario will bolster the market growth.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
U.S. Dialysis Market Size in 2022: | USD 42.1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 4% |
2032 Value Projection: | USD 61.3 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 330 |
Tables, Charts & Figures: | 788 |
Segments covered: | Tye, Products and Services, End-use, and Zone. |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Increasing concerns related to product recalls are expected to hamper the expansion of the U.S. dialysis market. Defects in hospital consumables and dialysis equipment have led to recalls that have slowed down industry development. Some issues like internal leaks in the dialysis apparatus during hemodialysis can cause cross-contamination between the catheters recirculating newly filtered blood which makes manufacturers recall their products. For instance, in January 2023, the union SEIU-United Healthcare Workers West requested the FDA to retract some Fresenius dialysis machines to protect patient safety.